Assessment of What Patients and Healthcare Providers Value
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).
Full description
PRIMARY OBJECTIVE:
I. To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience).
SECONDARY OBJECTIVES:
I. To assess which attributes of value (i.e., outcomes, QOL, cost, experience) health care providers (i.e., physicians, nurses, administrators) feel are most important in health care delivery.
II. To assess how these patients' views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).
III. To assess how patients' view differ to health providers.
OUTLINE:
Patients and healthcare providers complete a survey over 10-15 minutes.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Any patient who has been treated, or is anticipated to be treated, for potentially resectable, biopsy-proven pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma
- Providers involved in the care of gastric and pancreatic cancer patients. Providers will include non-collaborative surgical oncologists, medical oncologists, radiation oncologists, administrators, nurses, mid-level providers
- Able to understand the description of the study and willing to participate
Exclusion criteria
- Inability to read and answer questions in English
Trial design
397 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal